DSM Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$105M |
| 2 |
GoDaddy
GDDY
|
+$39M |
| 3 |
JD.com
JD
|
+$20.2M |
| 4 |
Boston Scientific
BSX
|
+$17.2M |
| 5 |
Burlington
BURL
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$93.5M |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$74.5M |
| 3 |
Automatic Data Processing
ADP
|
+$67.1M |
| 4 |
Microsoft
MSFT
|
+$55.4M |
| 5 |
Alibaba
BABA
|
+$42.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.04% |
| 2 | Consumer Discretionary | 22.36% |
| 3 | Communication Services | 15.85% |
| 4 | Financials | 14.59% |
| 5 | Healthcare | 7.93% |
Similar funds
DSM Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, DSM Capital Partners held 51 positions worth $9.01B, up 7.2% from $8.4B the previous quarter. Its ten largest holdings account for 73% of the portfolio.
DSM Capital Partners withdrew a net $349M in Q3 2020, closing 4 positions and reducing 22 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $74.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, DSM Capital Partners opened a new position in Stryker worth $9.96M.
- DSM Capital Partners's largest Q3 2020 buy was Stryker: 47,819 shares worth $9.96M.
- DSM Capital Partners added most to Meta Platforms (Facebook) in Q3 2020, an estimated $105M increase.
- DSM Capital Partners's biggest Q3 2020 reduction was Visa, cutting an estimated $93.5M.
- DSM Capital Partners fully exited Varian Medical Systems, Inc. in Q3 2020, selling an estimated $74.5M.
- DSM Capital Partners's ten largest holdings make up 73% of its $9.01B portfolio in Q3 2020.
- DSM Capital Partners opened 2 new positions and closed 4 in Q3 2020.
- DSM Capital Partners's portfolio value rose 7.2% quarter-over-quarter to $9.01B.
Based on DSM Capital Partners's 13F filing for Q3 2020, filed 13 Nov 2020.